title: Role of the fibrinolytic and matrix metalloproteinase systems in development of adipose tissue.
abstract: Obesity is a common disorder and related diseases such as diabetes, atherosclerosis, hypertension, cardiovascular disease and cancer are a major cause of mortality and morbidity in Western-type societies. Development of obesity is associated with extensive modifications in adipose tissue involving adipogenesis, angiogenesis and extracellular matrix proteolysis. The fibrinolytic (plasminogen/plasmin) and matrix metalloproteinase (MMP) systems cooperate in these processes. A nutritionally induced obesity model in transgenic mice has been used extensively to study the role of the fibrinolytic and MMP systems in the development of obesity. These studies support a role of both systems in adipogenesis and obesity; the role of specific members of these families, however, remains to be determined.
authors.affiliation: Center for Molecular and Vascular Biology, KULeuven, Leuven, Belgium.
authors.forename: Valerie
authors.initials: V
authors.lastname: Christiaens
authors.forename: H Roger
authors.initials: HR
authors.lastname: Lijnen
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism*; D000818:Animals; D004195:Disease Models, Animal; D005109:Extracellular Matrix / Q000378:metabolism*; D005341:Fibrinolysin / Q000378:metabolism*; D005342:Fibrinolysis; D006801:Humans; D020782:Matrix Metalloproteinases / Q000378:metabolism*; D051379:Mice; D008820:Mice, Obese; D009765:Obesity / Q000378:metabolism; D019714:Tissue Inhibitor of Metalloproteinases / Q000378:metabolism; D010959:Tissue Plasminogen Activator / Q000378:metabolism*
chemical_list: D019714:Tissue Inhibitor of Metalloproteinases; D010959:Tissue Plasminogen Activator; D005341:Fibrinolysin; D020782:Matrix Metalloproteinases